T-Cell Mediated Rejections Do Not Induce De Novo Donor Specific Antibodies in Non-Sensitized Kidney Transplant Recipients: A Longitudinal Cohort Analysis.

被引:0
|
作者
Chemouny, J. [1 ]
Suberbielle, C. [2 ]
Loupy, A. [1 ]
Legendre, C. [1 ]
Anglicheau, D. [1 ]
机构
[1] Hop Necker Enfants Malad, AP HP, Paris, France
[2] Hop St Louis, AP HP, Lab Reg Histocompatibilit, Paris, France
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:500 / 500
页数:1
相关论文
共 50 条
  • [21] DE NOVO DONOR SPECIFIC AND NON-DONOR SPECIFIC HLA ANTIBODIES AND SUBCLINICAL ANTIBODY MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS-12 MONTHS PROTOCOL BIOPSY STUDY
    Severova-Andreevska, Galina
    Trajceska, Lada
    Masin-Spasovska, Jelka
    Danilovska, Ilina
    Shikole, Aleksandar
    Ivanovski, Ninoslav
    TRANSPLANT INTERNATIONAL, 2017, 30 : 530 - 530
  • [22] Thymoglobulin Is Associated with a Significant Reduction in De Novo Donor-Specific Antibodies and Antibody Mediated Rejection in Moderately Sensitized Renal Transplant Recipients
    Mako, M.
    Hager, D.
    Muth, B.
    Kaufman, D.
    Ellis, T.
    Djamali, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 112 - 112
  • [23] Incidence of De Novo Donor Specific Antibodies After Early Steroid Withdrawal in Kidney Transplant Recipients.
    Majmundar, D.
    Karhadkar, S.
    Diamond, A.
    Au, J.
    Ruggia-Check, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 803 - 803
  • [24] Association of CXCR5 Polymorphisms with Detection of De Novo Donor Specific Antibodies in Kidney Transplant Recipients
    Ono, K.
    Ide, K.
    Nakano, R.
    Sakai, H.
    Tanimine, N.
    Tahara, H.
    Ohira, M.
    Tanaka, Y.
    Ohdan, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S489 - S490
  • [25] The Impact of Tacrolimus IPV and TTR on the Development of De Novo Donor-specific Antibodies in Kidney Transplant Recipients
    Xu, D.
    Richards, K.
    Zheng, K.
    Patel, H.
    Cardarelli, F.
    Pena, J. A.
    Aala, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 844 - 844
  • [26] Do We Need an Individually Tailored Immunosuppression Strategy for Living Donor Kidney Transplant Recipients with PreTransplant Donor Specific Antibodies? A Retrospective Analysis.
    Bhutani, S.
    Ponnusamy, A.
    Tak, Q.
    Shah, S.
    Worthington, J.
    Summers, A.
    Poulton, K.
    Van Dellen, D.
    Morton, M.
    Picton, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 543 - 543
  • [27] Antithymocyte Globulin Is Associated With a Lower Incidence of De Novo Donor-Specific Antibodies in Moderately Sensitized Renal Transplant Recipients
    Brokhof, Marissa M.
    Sollinger, Hans W.
    Hager, David R.
    Muth, Brenda L.
    Pirsch, John D.
    Fernandez, Luis A.
    Bellingham, Janet M.
    Mezrich, Joshua D.
    Foley, David P.
    D'Alessandro, Anthony M.
    Odorico, Jon S.
    Mohamed, Maha A.
    Vidyasagar, Vijay
    Ellis, Thomas M.
    Kaufman, Dixon B.
    Djamali, Arjang
    TRANSPLANTATION, 2014, 97 (06) : 612 - 617
  • [28] Association of PIRCHE-II score with anti-donor T-cell response and risk of de novo donor-specific antibody production in kidney transplant recipients
    Yamane, Hiroaki
    Ide, Kentaro
    Tanaka, Yuka
    Ohira, Masahiro
    Tahara, Hiroyuki
    Shimizu, Seiichi
    Sakai, Hiroshi
    Nakano, Ryosuke
    Ohdan, Hideki
    TRANSPLANT IMMUNOLOGY, 2024, 87
  • [29] CLINICAL SIGNIFICANCE OF DE NOVO DONOR SPECIFIC ANTIBODY IN KIDNEY TRANSPLANT RECIPIENTS WITH CHRONIC ANTIBODY-MEDIATED REJECTION
    Park, Woo Yeong
    Paek, Jin Hyuk
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    TRANSPLANT INTERNATIONAL, 2019, 32 : 102 - 102
  • [30] Development and outcomes of de novo donor-specific antibodies in low, moderate, and high immunological risk kidney transplant recipients
    Wan, Susan S.
    Chadban, Steven J.
    Watson, Narelle
    Wyburn, Kate
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (05) : 1351 - 1364